blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

Technologies and tools enabling precision patient finding

There are a number of innovative tools and technologies which are enabling precision patient finding. From AI to e-consent, here we explore how they are changin...
Continue reading

Podcast recap: Dr. Luis Diaz on immunotherapy, liquid biopsies, and the future of cancer detection

In the latest episode of The Genetics Podcast, Patrick Short was joined by Dr. Luis Diaz, head of the Division of Solid Tumor Oncology at Memorial Sloan Ketteri...
Continue reading

Podcast recap: Dr. Susan Liebman on genetic testing, advocacy, and the power of storytelling

On a recent episode of The Genetics Podcast, Patrick Short speaks with Dr. Susan Liebman, a professor emerita and researcher, about her personal and professiona...
Continue reading

How precision patient finding reduces research costs

Precision patient finding has the potential to radically reduce the cost of trials and create a more centralized approach which serves to benefit a multitude of...
Continue reading

Precision patient finding: the key to speed, savings, and trial success in biotech [whitepaper]

Clinical trials are essential for bringing new treatments to patients, but they’re not without challenges. Recruiting the right participants, staying on budget,...
Continue reading

What is precision patient finding?

Precision patient finding is an evolving field that is growing in line with the demands of precision medicine and rare disease research. Unlike traditional pati...
Continue reading

Overcoming challenges in precision neurology

Implementing precision neurology comes with its own set of complexities—from decoding the brain's intricate workings to addressing the ethical challenges of usi...
Continue reading

Podcast recap: Dr. Jim Wilson on the genetics of isolated communities

In the latest episode of The Genetics Podcast, Patrick speaks with Dr. Jim Wilson, Professor of Human Genetics at the University of Edinburgh, about his work st...
Continue reading

Neuron23 Unveils Groundbreaking Phase 2 Trial in Early Parkinson’s Disease

Sano is proud to support Neuron23 in the NEULARK Phase 2 clinical trial, a groundbreaking study exploring NEU-411, a brain-penetrant LRRK2 inhibitor with the po...
Continue reading

Podcast recap: Michelle Teng on transforming immunotherapy with machine learning

Last week on The Genetics Podcast, Patrick Short sat down with Michelle Teng, CEO and co-founder of Etcembly, to explore her work at the intersection of immunot...
Continue reading